<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:25:01Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8226364" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8226364</identifier>
        <datestamp>2021-07-06</datestamp>
        <setSpec>ict</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" xml:lang="en" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Integr Cancer Ther</journal-id>
              <journal-id journal-id-type="iso-abbrev">Integr Cancer Ther</journal-id>
              <journal-id journal-id-type="publisher-id">ICT</journal-id>
              <journal-id journal-id-type="hwp">spict</journal-id>
              <journal-title-group>
                <journal-title>Integrative Cancer Therapies</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1534-7354</issn>
              <issn pub-type="epub">1552-695X</issn>
              <publisher>
                <publisher-name>SAGE Publications</publisher-name>
                <publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8226364</article-id>
              <article-id pub-id-type="pmcid">PMC8226364</article-id>
              <article-id pub-id-type="pmc-uid">8226364</article-id>
              <article-id pub-id-type="pmid">34160294</article-id>
              <article-id pub-id-type="pmid">34160294</article-id>
              <article-id pub-id-type="doi">10.1177/15347354211026757</article-id>
              <article-id pub-id-type="publisher-id">10.1177_15347354211026757</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>The Effects of Kinect-Enhanced Lymphatic Exercise Intervention on
Lymphatic Pain, Swelling, and Lymph Fluid Level</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3891-0109</contrib-id>
                  <name>
                    <surname>Fu</surname>
                    <given-names>Mei R.</given-names>
                  </name>
                  <degrees>PhD, RN, FAAN</degrees>
                  <xref rid="aff1-15347354211026757" ref-type="aff">1</xref>
                  <xref rid="corresp1-15347354211026757" ref-type="corresp"/>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5151-8307</contrib-id>
                  <name>
                    <surname>McTernan</surname>
                    <given-names>Melissa L.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff2-15347354211026757" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Qiu</surname>
                    <given-names>Jeanna M.</given-names>
                  </name>
                  <degrees>AB</degrees>
                  <xref rid="aff3-15347354211026757" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ko</surname>
                    <given-names>Eunjung</given-names>
                  </name>
                  <degrees>MSN, RN, AGPCNP-BC</degrees>
                  <xref rid="aff4-15347354211026757" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yazicioglu</surname>
                    <given-names>Simay</given-names>
                  </name>
                  <degrees>Undergraduate Research Assistant</degrees>
                  <xref rid="aff5-15347354211026757" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Axelrod</surname>
                    <given-names>Deborah</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff6-15347354211026757" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Guth</surname>
                    <given-names>Amber</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff6-15347354211026757" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Fan</surname>
                    <given-names>Zhipeng</given-names>
                  </name>
                  <degrees>PhD Student</degrees>
                  <xref rid="aff5-15347354211026757" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sang</surname>
                    <given-names>Anna</given-names>
                  </name>
                  <degrees>Undergraduate Research Assistant</degrees>
                  <xref rid="aff7-15347354211026757" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Miaskowski</surname>
                    <given-names>Christine</given-names>
                  </name>
                  <degrees>RN, PhD, FAAN</degrees>
                  <xref rid="aff8-15347354211026757" ref-type="aff">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Yao</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff5-15347354211026757" ref-type="aff">5</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1-15347354211026757"><label>1</label>Boston College William F. Connell
School of Nursing, Chestnut Hill, MA, USA</aff>
              <aff id="aff2-15347354211026757"><label>2</label>Boston College, Research Services,
Chestnut Hill, MA, USA</aff>
              <aff id="aff3-15347354211026757"><label>3</label>Harvard Medical School, Boston, MA,
USA</aff>
              <aff id="aff4-15347354211026757"><label>4</label>The Ohio State University College of
Nursing, Columbus, OH, USA</aff>
              <aff id="aff5-15347354211026757"><label>5</label>New York University Tandon School of
Engineering, Brooklyn, NY, USA</aff>
              <aff id="aff6-15347354211026757"><label>6</label>New York University School of Medicine,
New York, NY, USA</aff>
              <aff id="aff7-15347354211026757"><label>7</label>New York University College of Arts and
Science, New York, NY, USA</aff>
              <aff id="aff8-15347354211026757"><label>8</label>University of California, San
Francisco, CA, USA</aff>
              <author-notes>
                <corresp id="corresp1-15347354211026757">Mei Rosemary Fu, Boston College William F.
Connell School of Nursing, Maloney Hall, 228, 140 Commonwealth Avenue, Chestnut
Hill, MA 02467, USA. Email: <email>qiumc@bc.edu</email> or
<email>mf67@nyu.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>23</day>
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>20</volume>
              <elocation-id>15347354211026757</elocation-id>
              <history>
                <date date-type="received">
                  <day>2</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
                <date date-type="rev-recd">
                  <day>12</day>
                  <month>5</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>2</day>
                  <month>6</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder content-type="sage">SAGE Publications</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which
permits non-commercial use, reproduction and distribution of the work
without further permission provided the original work is attributed as
specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <sec id="section1-15347354211026757">
                  <title>Background:</title>
                  <p><italic toggle="yes">The-Optimal-Lymph-Flow</italic> (TOLF) intervention aims to promote
lymph flow through therapeutic lymphatic exercises to relieve lymphatic
pain, swelling, lymphedema symptoms, and to decrease lymph fluid levels
among breast cancer survivors. To enhance the efficacy of the TOLF
intervention, an innovative, intelligent, Kinect-enhanced lymphatic exercise
intervention (Kinect-TOLF) was developed to teach patients to perform the
lymphatic exercises correctly.</p>
                </sec>
                <sec id="section2-15347354211026757">
                  <title>Objectives:</title>
                  <p>This feasibility trial aimed to determine the feasibility, usability, and
effects of the Kinect-TOLF on lymphatic pain, swelling, lymphedema symptoms,
and lymph fluid levels.</p>
                </sec>
                <sec id="section3-15347354211026757">
                  <title>Methods:</title>
                  <p>A single-arm feasibility trial with a pre- and post-test design was employed
to recruit 30 breast cancer survivors with persistent lymphatic pain or
swelling. Patients received a single training session to learn how to
perform the lymphatic exercises using the Kinect-TOLF program. Descriptive
statistics, Wilcoxon signed-rank tests, <italic toggle="yes">t</italic>-test, Spearman’s
rank correlation coefficients, linear regressions, and Cohen’s
<italic toggle="yes">d</italic> were performed for data analysis. Qualitative data
were assessed for common themes.</p>
                </sec>
                <sec id="section4-15347354211026757">
                  <title>Results:</title>
                  <p>The Kinect-TOLF was effective in training patients to perform the lymphatic
exercises correctly with high user satisfaction. Significant reductions were
found in scores of lymphatic pain (<italic toggle="yes">Med</italic><sub>Δ</sub> = −1.00,
CI <italic toggle="yes">=</italic> [−1.5, −0.1], <italic toggle="yes">P</italic> = .004), arm/hand
swelling (<italic toggle="yes">Med</italic><sub>Δ</sub> = −1.00, CI = [−1.5, −0.5],
<italic toggle="yes">P</italic> = .004), total swelling
(<italic toggle="yes">Med</italic><sub>Δ</sub> = −1.5, CI = [−2.0, −1.0],
<italic toggle="yes">P</italic> = .003), number of lymphedema symptoms
(<italic toggle="yes">M</italic><sub>Δ</sub> = −3.8, CI = [−5.5, −2.1],
<italic toggle="yes">P</italic> &lt; .001), and lymphedema symptom severity
(<italic toggle="yes">M</italic><sub>Δ</sub> = −5.3, CI = [−9.5, −1.1],
<italic toggle="yes">P</italic> = .016). A significant reduction in lymph fluid
levels was found in mean L-Dex scores
(<italic toggle="yes">M</italic><sub>Δ</sub> = −2.68, CI = [−4.67, −0.69],
<italic toggle="yes">P</italic> = .010). Greater decrease in mean L-Dex scores were
found in patients with abnormal lymph fluid levels (L-Dex ≥ 7.1)
(<italic toggle="yes">M</italic><sub>Δ</sub> = −5.19, CI = [−1.75, −8.63],
<italic toggle="yes">P</italic> = .008). Patients’ qualitative feedback supported the
results of the study.</p>
                </sec>
                <sec id="section5-15347354211026757">
                  <title>Conclusions:</title>
                  <p>The Kinect-TOLF is safe, feasible, and effective in reducing lymphatic pain,
swelling, lymphedema symptoms, and in decreasing lymph fluid levels. Future
research should focus on a randomized clinical trial to confirm the unique
or synergistic efficacy of the Kinect-TOLF in comparison with current
lymphedema treatment and other forms of exercises or movement therapy. This
study was registered in ClinicalTrials.gov with US ClinicalTrials.gov
Identifier: NCT03999177.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>lymphatic</kwd>
                <kwd>pain</kwd>
                <kwd>swelling</kwd>
                <kwd>lymphedema</kwd>
                <kwd>lymph fluid</kwd>
                <kwd>breast cancer</kwd>
                <kwd>symptoms</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group id="award1-15347354211026757">
                  <funding-source id="funding1-15347354211026757">
                    <institution-wrap>
                      <institution>national science foundation</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000001</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding1-15347354211026757">1R01CA214085-01</award-id>
                </award-group>
                <award-group id="award2-15347354211026757">
                  <funding-source id="funding2-15347354211026757">
                    <institution-wrap>
                      <institution>Judges and Lawyers Breast Cancer Alert</institution>
                      <institution-id/>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>January-December 2021</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>typesetter</meta-name>
                  <meta-value>ts1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="section6-15347354211026757">
              <title>Introduction</title>
              <p>Lymphatic pain, swelling, and lymphedema symptoms are ongoing debilitating adverse
effects of cancer treatment that elicit distress and negative impacts on breast
cancer survivors’ quality of life (QOL).<sup><xref rid="bibr1-15347354211026757" ref-type="bibr">1</xref><xref rid="bibr2-15347354211026757" ref-type="bibr"/>-<xref rid="bibr3-15347354211026757" ref-type="bibr">3</xref></sup> Breast cancer survivors have a
compromised lymphatic system due to cancer treatment,<sup><xref rid="bibr4-15347354211026757" ref-type="bibr">4</xref><xref rid="bibr5-15347354211026757" ref-type="bibr"/>-<xref rid="bibr6-15347354211026757" ref-type="bibr">6</xref></sup> resulting in an accumulation of
lymph fluid in the ipsilateral body or upper limb.<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref><xref rid="bibr8-15347354211026757" ref-type="bibr"/>-<xref rid="bibr9-15347354211026757" ref-type="bibr">9</xref></sup> The accumulation of lymph fluid
leads to a chronic and co-occurring variety of pain sensations (i.e.,
pain/aching/soreness) in the ipsilateral upper limb or body defined as lymphatic
pain and other symptoms related to fluid accumulation defined as lymphedema
symptoms.<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref><xref rid="bibr8-15347354211026757" ref-type="bibr"/>-<xref rid="bibr9-15347354211026757" ref-type="bibr">9</xref></sup> Both swelling
and lymphedema are caused by an abnormal accumulation of lymph fluid in the
ipsilateral body or upper limb.<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref></sup> Swelling often refers to patient-reported symptom. Lymphedema is often
defined as an increased limb size or girth comparing affected (or lymphedematous)
and unaffected limbs.<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref><xref rid="bibr8-15347354211026757" ref-type="bibr"/>-<xref rid="bibr9-15347354211026757" ref-type="bibr">9</xref></sup></p>
              <p>While lymphatic pain, swelling, and lymphedema symptoms are most common in patients
with a diagnosis of lymphedema,<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref></sup> more than 50% of breast cancer survivors without a diagnosis of lymphedema
also report daily co-occurring lymphatic pain, swelling, and lymphedema
symptoms.<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref><xref rid="bibr8-15347354211026757" ref-type="bibr"/>-<xref rid="bibr9-15347354211026757" ref-type="bibr">9</xref></sup> For breast
cancer survivors without a diagnosis of lymphedema, the experience of lymphatic
pain, swelling, and lymphedema symptoms is a cardinal sign of an early stage of
lymphedema because these symptoms often precede changes in limb size or girth and a
lymphedema diagnosis.<sup><xref rid="bibr8-15347354211026757" ref-type="bibr">8</xref>,<xref rid="bibr9-15347354211026757" ref-type="bibr">9</xref></sup>
Breast cancer survivors who report pain on the affected ipsilateral upper limb or
body are nearly twice as likely to develop lymphedema.<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref></sup> Without timely intervention in this early stage, lymphedema can progress into
a chronic condition that no surgical or medical interventions can cure.<sup><xref rid="bibr10-15347354211026757" ref-type="bibr">10</xref>,<xref rid="bibr11-15347354211026757" ref-type="bibr">11</xref></sup> Thus, the
effective management of lymphatic pain, swelling, and lymphedema symptoms is needed
for breast cancer survivors with or without a diagnosis of lymphedema.</p>
              <p>Pharmacological interventions (eg, NSAIDs, opioids) and behavioral strategies are
commonly used for pain control in cancer patients.<sup><xref rid="bibr11-15347354211026757" ref-type="bibr">11</xref><xref rid="bibr12-15347354211026757" ref-type="bibr"/><xref rid="bibr13-15347354211026757" ref-type="bibr"/><xref rid="bibr14-15347354211026757" ref-type="bibr"/><xref rid="bibr15-15347354211026757" ref-type="bibr"/>-<xref rid="bibr16-15347354211026757" ref-type="bibr">16</xref></sup> Lymphedema treatments (e.g.,
manual lymph drainage, physical therapy, compression garments, upper extremity
exercise, yoga) are used to control swelling.<sup><xref rid="bibr11-15347354211026757" ref-type="bibr">11</xref></sup> Research is limited on the efficacy of interventions that target
physiological factors (e.g., the compromised lymphatic drainage) to manage lymphatic
pain, swelling, and lymphedema symptoms. <italic toggle="yes">The-Optimal-Lymph-Flow</italic>
(TOLF) intervention, a patient-centered and nurse-led self-care program, aims to
promote lymph flow through the performance of therapeutic lymphatic exercises and
strategies to achieve nutrition-balanced, portion-appropriate diet, adequate
hydration, and proper sleep to minimize the risk of lymphedema.<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/>-<xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup> The therapeutic lymphatic
exercises include a set of muscle-tightening deep breathing and muscle-tightening
pumping and shoulder exercises. <xref rid="table1-15347354211026757" ref-type="table">Table 1</xref> describes the physiologic
rationale for each lymphatic exercise. The efficacy of the TOLF intervention to
prevent lymph fluid accumulation was demonstrated in a clinical trial with 140
patients after breast cancer surgery.<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref></sup> The efficacy of TOLF for lymphatic pain was demonstrated in a 12-week pilot
feasibility clinical trial that used a mobile avatar-based coaching system to
deliver the TOLF intervention.<sup><xref rid="bibr18-15347354211026757" ref-type="bibr">18</xref></sup></p>
              <table-wrap position="float" id="table1-15347354211026757">
                <label>Table 1.</label>
                <caption>
                  <p>Kinect-Enhanced Lymphatic Exercise Intervention (Kinect-TOLF).</p>
                </caption>
                <alternatives>
                  <graphic xlink:href="10.1177_15347354211026757-table1" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" span="1"/>
                      <col align="char" char="." span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">Lymphatic exercises</th>
                        <th align="center" rowspan="1" colspan="1">Physiological rationales</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="4" colspan="1">Muscle-tightening deep breathing</td>
                        <td rowspan="1" colspan="1">Whole body lymph fluid has to be drained through the lymphatic
ducts above the heart. Muscle-tightening-deep-breathing
stimulates lymphatic ducts to promote lymph fluid draining.</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Lymph fluid drains when muscles move.
Muscle-tightening-deep-breathing creates the whole body muscle
movements that create muscle milking and pumping action and help
drain lymph fluid.</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Deep breathing enhances muscle pumping in the upper body by
contracting the external intercostal muscles, the accessory
muscles of inspiration, and the diaphragm during inspiration and
the internal intercostal muscles and abdominal muscles during
expiration.</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Deep breathing decreases oxidative stress and oxygenates body
tissues. It decreases inflammation and promotes wound
healing.</td>
                      </tr>
                      <tr>
                        <td rowspan="2" colspan="1">Muscle-tightening pumping<break/> Over-the-head
pumping<break/> Horizontal pumping<break/> Push-down
pumping</td>
                        <td rowspan="1" colspan="1">Muscle-tightening pumping exercises create arm muscle milking
and pumping, including the main anterior upper arm muscles
(biceps brachii, brachialis, coracobrachialis), the posterior
muscle of triceps brachii, and deltoid muscle (ie, the anterior
deltoid, lateral deltoid, and posterior deltoid). The pumping of
these muscles increases lymph fluid flow and decreases the fluid
build-up in the arms.</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Muscle-tightening pumping exercises build the arm muscles that
help lymph fluid flow and drain.</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Shoulder exercises<break/> Shoulder rolls<break/> Clasp and
spread<break/> Reach to the sky</td>
                        <td rowspan="1" colspan="1">Improved limb mobility facilitates local muscle movements that
create muscle milking and pumping to promote lymph fluid flow
and drainage.<break/>Shoulder exercises create arm muscle
milking and pumping by moving the main anterior upper arm
muscles (biceps brachii, brachialis, coracobrachialis), the
posterior muscle of triceps brachii, and deltoid muscle (ie, the
anterior deltoid, lateral deltoid, and posterior deltoid).</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
              </table-wrap>
              <p>To enhance the efficacy of the TOLF intervention, we developed and tested a
Kinect-enhanced lymphatic exercise intervention system (Kinect-TOLF) that uses a
Microsoft Kinect sensor to capture both color and depth information while the
patient is performing the lymphatic exercises following an avatar on a screen (<xref rid="fig1-15347354211026757" ref-type="fig">Figure 1</xref>).<sup><xref rid="bibr20-15347354211026757" ref-type="bibr">20</xref><xref rid="bibr21-15347354211026757" ref-type="bibr"/>-<xref rid="bibr22-15347354211026757" ref-type="bibr">22</xref></sup> The Kinect-TOLF accurately
aligns a user’s motion sequence with the standard motion sequence and evaluates the
“correctness” of the user’s movements in real time. This approach facilitates
instantaneous feedback to the user while the user is performing each exercise.</p>
              <fig position="float" id="fig1-15347354211026757">
                <label>Figure 1.</label>
                <caption>
                  <p>Kinect-enhanced lymphatic exercise intervention.</p>
                </caption>
                <graphic xlink:href="10.1177_15347354211026757-fig1" position="float"/>
              </fig>
              <p>We conducted a single-arm feasibility clinical trial with a pre- and post-test design
to assess the feasibility and usability of the Kinect-TOLF to deliver a therapeutic
lymphatic exercise intervention to breast cancer survivors. The objectives of this
trial were to: (1) evaluate the Kinect-TOLF in breast cancer survivors in terms of
feasibility (i.e., study accrual and protocol adherence) and usability (i.e.,
ratings of training quality, system quality, and behavioral intention of using the
Kinect-TOLF); and (2) test the efficacy of the Kinect-TOLF on reductions in
lymphatic pain, swelling, lymphedema symptom occurrence (i.e., number and severity
of symptoms), and lymph fluid levels. We hypothesized that a single session of
Kinect-TOLF intervention would lead to significant reductions in lymphatic pain,
swelling, lymphedema symptom occurrence (i.e., number and severity of symptoms), and
lymph fluid levels. This study was registered in ClinicalTrials.gov with US
ClinicalTrials.gov Identifier: NCT03999177.</p>
            </sec>
            <sec sec-type="methods" id="section7-15347354211026757">
              <title>Methods</title>
              <sec id="section8-15347354211026757">
                <title>Ethical Approval</title>
                <p>This study (S19-00222) was approved by the Institutional Review Board of NYU
Langone Health, in New York, United States.</p>
              </sec>
              <sec id="section9-15347354211026757">
                <title>Study Design</title>
                <p>This study was a single-arm, single-center, feasibility clinical trial that
utilized a pre- and post-test design. Feasibility of the study was defined as
study accrual (N = 30) in 6 months of recruitment and &gt;80% of protocol
adherence defined as participants’ completion of the Kinect-TOLF training for
lymphatic exercises. We assessed the usability of the Kinect-TOLF in terms of
the extent that the user interface met Nielsen’s principles for usability (i.e.,
learnability, efficiency, memorability, errors, satisfaction).<sup><xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref><xref rid="bibr24-15347354211026757" ref-type="bibr"/>-<xref rid="bibr25-15347354211026757" ref-type="bibr">25</xref></sup></p>
              </sec>
              <sec id="section10-15347354211026757">
                <title>Setting</title>
                <p>The study was conducted in a nursing research laboratory located in the breast
cancer clinic of New York University Perlmutter Cancer Center, a National Cancer
Institute designated cancer center in New York City, US.</p>
              </sec>
              <sec id="section11-15347354211026757">
                <title>Participants</title>
                <p>Participants were recruited from among the consecutively-identified breast cancer
survivors who reported persistent lymphatic pain or swelling in the ipsilateral
upper limb or body at least 12 weeks after breast cancer surgery during routine
clinical visits. A total of 30 patients were recruited from July 26 to September
3, 2019. All patients signed a written consent. <xref rid="fig2-15347354211026757" ref-type="fig">Figure 2</xref> presents the Patient Flow
Chart.</p>
                <fig position="float" id="fig2-15347354211026757">
                  <label>Figure 2.</label>
                  <caption>
                    <p>Patient flow chart.</p>
                  </caption>
                  <graphic xlink:href="10.1177_15347354211026757-fig2" position="float"/>
                </fig>
                <p>Patients who met the following inclusion criteria were recruited. Inclusion
criteria were women who (a) had received surgical treatment for Stage I-III
breast cancer, including mastectomy, lumpectomy, sentinel lymph node biopsy
(SLNB), SLNB plus lymph node dissection or axillary lymph node dissection
(ALND);<sup><xref rid="bibr5-15347354211026757" ref-type="bibr">5</xref>,<xref rid="bibr6-15347354211026757" ref-type="bibr">6</xref></sup> (b) reported persistent pain or swelling in the ipsilateral
upper limb or body at least 12 weeks after surgery; (c) may or may not have had
neoadjuvant or adjuvant therapy of chemotherapy or radiation; (d) may or may not
have had a history of or being treated for lymphedema;<sup><xref rid="bibr5-15347354211026757" ref-type="bibr">5</xref>,<xref rid="bibr6-15347354211026757" ref-type="bibr">6</xref></sup> and (e) were able to speak
and understand English. Patients were excluded if they had (a) known metastatic
disease, cancer recurrence, or lymphedema due to cancer recurrence, or other
bulk disease in the thoracic or cervical regions; and (b) renal or heart
failure, a cardiac pacemaker or defibrillator, artificial limbs, or were
pregnant.</p>
              </sec>
              <sec id="section12-15347354211026757">
                <title>Sample Size</title>
                <p>The primary objective of this study was to determine the feasibility and
usability of the Kinect-TOLF. The end-users of the Kinect-TOLF are breast cancer
survivors with persistent lymphatic pain or swelling. A relatively small sample
size of 10 to 15 end-users is recommended for usability testing.<sup><xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref>,<xref rid="bibr24-15347354211026757" ref-type="bibr">24</xref></sup> A sample
of 30 patients who represented the end-users of the breast cancer survivors with
persistent lymphatic pain or swelling was appropriate for the
feasibility<sup><xref rid="bibr26-15347354211026757" ref-type="bibr">26</xref>,<xref rid="bibr27-15347354211026757" ref-type="bibr">27</xref></sup> and usability testing.<sup><xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref>,<xref rid="bibr24-15347354211026757" ref-type="bibr">24</xref></sup></p>
              </sec>
              <sec id="section13-15347354211026757">
                <title>Study Procedures</title>
                <p>Kinect for Windows SDK 2.0 was installed on a study laptop and the Kinect sensor
was connected to the laptop. Prior to the Kinect-TOLF training session,
demographic, and clinical data were collected, BMI and intervention outcomes
were assessed. The intervention outcomes were assessed in the same order prior
to and after training (i.e., lymphatic pain, arm/hand swelling, lymphedema
symptoms, lymph fluid level). Upon the completion of the single training
session, each patient was instructed to sit and rest for 5 minutes, followed by
post training assessment of the intervention outcomes. In addition, patients
were asked to complete the usability questionnaires and qualitative evaluation
of the training. All the self-reported questionnaires were administered to the
participants electronically via a study iPad connected to the study specific
electronic database capture system. Two researchers who were not involved in the
Kinect-TOLF training assessed patients’ lymph fluid levels using a bioimpedance
device independently prior to and after the training session.</p>
                <p>To evaluate usability of the Kinect-TOLF, we completed a heuristic evaluation
with each patient. A heuristic evaluation is a usability inspection method in
which a relatively small group of end-users examine the extent to which a user
interface meets Nielsen's principles for usability.<sup><xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref>,<xref rid="bibr24-15347354211026757" ref-type="bibr">24</xref></sup> These principles include
visibility of system status; the match between the system and the real world;
user control and freedom; recognition rather than recall; and flexibility and
efficiency of use.<sup><xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref><xref rid="bibr24-15347354211026757" ref-type="bibr"/>-<xref rid="bibr25-15347354211026757" ref-type="bibr">25</xref></sup> Each
patient completed a set of specified tasks designed to explicate system features
and freely explore the prototype. Then, patients completed a heuristic
evaluation checklist that included ratings of the severity of heuristic
violations (i.e., no usability problem, cosmetic problem, minor usability
problem, major usability problem, usability catastrophe).</p>
                <p>We used an iterative process to test the usability and acceptance of the
Kinect-TOLF and refine the program based on patients’ “think aloud” comments
during the training sessions.<sup><xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref>,<xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref><xref rid="bibr24-15347354211026757" ref-type="bibr"/>-<xref rid="bibr25-15347354211026757" ref-type="bibr">25</xref></sup> The “think aloud” method
generated data on patients’ ongoing thought processes as they completed a set of
training tasks designed to explicate system features.<sup><xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref>,<xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref><xref rid="bibr24-15347354211026757" ref-type="bibr"/>-<xref rid="bibr25-15347354211026757" ref-type="bibr">25</xref></sup> Only a few refinements
were made based on patients’ comments, such as motion synchronization when
patients performed the exercises (<xref rid="fig3-15347354211026757" ref-type="fig">Figure 3</xref>).</p>
                <fig position="float" id="fig3-15347354211026757">
                  <label>Figure 3.</label>
                  <caption>
                    <p>Refinement of the Kinect-enhanced lymphatic exercise training system.</p>
                  </caption>
                  <graphic xlink:href="10.1177_15347354211026757-fig3" position="float"/>
                </fig>
              </sec>
              <sec id="section14-15347354211026757">
                <title>The Kinect-TOLF Lymphatic Exercise Intervention</title>
                <p>As an essential component of <italic toggle="yes">The-Optimal-Lymph-Flow</italic> (TOLF)
intervention,<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref>,<xref rid="bibr18-15347354211026757" ref-type="bibr">18</xref></sup> the Kinect-TOLF is an innovative and intelligent
Kinect-enhanced lymphatic exercise intervention that teaches patients to perform
correctly the lymphatic exercises (<xref rid="table1-15347354211026757" ref-type="table">Table 1</xref>).<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/><xref rid="bibr19-15347354211026757" ref-type="bibr"/><xref rid="bibr20-15347354211026757" ref-type="bibr"/><xref rid="bibr21-15347354211026757" ref-type="bibr"/>-<xref rid="bibr22-15347354211026757" ref-type="bibr">22</xref></sup> The Kinect-TOLF is
intelligent in that it can automatically detect whether a user is performing the
set of lymphatic exercises correctly in real time and provide instantaneous
feedback to the user while the user is following the avatar model in the video
to perform the lymphatic exercises. This approach enhances patients’
self-efficacy to perform the lymphatic exercises correctly. The therapeutic
lymphatic exercises are safe and were found to be efficacious in prior
studies.<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/>-<xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup> The
Kinect-TOLF uses the Kinect v2 sensor that is commercially available and widely
used in video games.<sup><xref rid="bibr20-15347354211026757" ref-type="bibr">20</xref><xref rid="bibr21-15347354211026757" ref-type="bibr"/>-<xref rid="bibr22-15347354211026757" ref-type="bibr">22</xref></sup> No
foreseeable risks are associated with the use of the Kinect-TOLF.<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/><xref rid="bibr19-15347354211026757" ref-type="bibr"/><xref rid="bibr20-15347354211026757" ref-type="bibr"/><xref rid="bibr21-15347354211026757" ref-type="bibr"/>-<xref rid="bibr22-15347354211026757" ref-type="bibr">22</xref></sup> No injuries and
complaints were reported with these exercises in previous studies<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/>-<xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup> as well as in this study.
Each patient received a single training session to learn how to perform the
lymphatic exercises using the Kinect-TOLF program. The training session ended
when the patient was able to perform each of the 7 lymphedema exercises
correctly using the Kinect-TOLF. The duration of the training session was 10 to
15 minutes.</p>
              </sec>
              <sec id="section15-15347354211026757">
                <title>Measures and Outcome Variables</title>
                <p><italic toggle="yes">Clinical and Demographic Information</italic> were collected from
patients’ self-reports and medical record reviews, including age, financial
status, types of surgeries, time since surgery, lymph nodes procedure(s), and
receipt of radiation and chemotherapy. Height and weight were measured and body
mass index [BMI] calculated.</p>
                <p><italic toggle="yes">The Perceived Ease of Use and Usefulness Questionnaire</italic> is a
valid and reliable 8-item instrument to evaluate users’ acceptance of a new
information system.<sup><xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref>,<xref rid="bibr28-15347354211026757" ref-type="bibr">28</xref>,<xref rid="bibr29-15347354211026757" ref-type="bibr">29</xref></sup> Items were rated on a 5-point Likert Scale that ranged
from 2 (strongly agree) to −2 (strongly disagree).<sup><xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup></p>
                <p><italic toggle="yes">The Post Study System Usability Questionnaire</italic> was used to assess
user satisfaction with system usability on a Likert scale that ranged from 1
(strongly agree) to 7 (strongly disagree).<sup><xref rid="bibr30-15347354211026757" ref-type="bibr">30</xref></sup> A modified 13-item tool that focused on the system’s usefulness and
information quality was used in the study.<sup><xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup> The questionnaire consists of 3 subscales, namely: system usefulness,
information quality, and interface quality. The overall reliability of the scale
was .97.<sup><xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref>,<xref rid="bibr30-15347354211026757" ref-type="bibr">30</xref></sup></p>
                <p><italic toggle="yes">Breast Cancer and Lymphedema Symptom Experience Index (BCLE-SEI)</italic>
was used to assess lymphatic pain (i.e., pain/aching/soreness), arm/hand
swelling, total swelling (i.e., sum of arm/hand, breast, and chest wall
swelling), and lymphedema symptom occurrence (i.e., number and severity of
lymphedema symptoms), including impaired limb mobility in shoulder, arm, elbow,
wrist, fingers, firmness, tightness, heaviness, fibrosis (toughness or thickness
of skin), stiffness, tenderness, hotness/increased temperature, redness,
blistering, numbness, burning, stabbing, tingling (pain and needles), limb
fatigue/weakness, and seroma (pocket of fluid developed).<sup><xref rid="bibr7-15347354211026757" ref-type="bibr">7</xref><xref rid="bibr8-15347354211026757" ref-type="bibr"/>-<xref rid="bibr9-15347354211026757" ref-type="bibr">9</xref>,18,31</sup> Adequate internal
consistency was demonstrated with a Cronbach’s alpha of .92 for symptom
occurrence. Discriminant validity of the instrument was supported by a
significant difference in symptom occurrence (<italic toggle="yes">z</italic> = −6.938,
<italic toggle="yes">P</italic> &lt; .000) between breast cancer survivors with and
without lymphedema.<sup><xref rid="bibr18-15347354211026757" ref-type="bibr">18</xref>,<xref rid="bibr31-15347354211026757" ref-type="bibr">31</xref></sup> The occurrence and severity of each of the 24
lymphedema symptom were evaluated. Symptom severity was rated on a Likert scale
that ranged from “0” (absence of a symptom) to “4” (presence of a symptom).
Higher scores indicate more severe symptoms. A response frame of “now” was used
when rating each symptom before and after the intervention.</p>
                <p><italic toggle="yes">Lymph Fluid Level by Bioimpedance</italic> was assessed using the Imp
XCA<sup>®</sup> (Impedimed, Brisbane, Australia), a bioelectrical impedance
analysis (BIA) device before and after the intervention. The device measures the
resistance of the extracellular fluid (i.e., the impedance) in terms of the
L-Dex ratio, taking into consideration the ratio between the dominant and
non-dominant arms.<sup><xref rid="bibr32-15347354211026757" ref-type="bibr">32</xref>,<xref rid="bibr33-15347354211026757" ref-type="bibr">33</xref></sup> With accumulation of lymph fluid, the impedance of the
limb decreases and the L-Dex ratio increases. The normal L-Dex ratio ranges from
−10 to +10, equivalent to impedance ratios of .935 to 1.139 for the affected
dominant arm and .862 to 1.066 for the non-affected non-dominant arm,
respectively. A L-Dex ratio &lt;−10 indicates a mistake in performing the
measurement. A L-Dex ratio of ≥7.1 indicates that a patient has an abnormal
accumulation of lymph fluid or lymphedema; the higher L-Dex ratio indicates the
greater severity of abnormal accumulation of lymph fluid or
lymphedema.<sup><xref rid="bibr32-15347354211026757" ref-type="bibr">32</xref>,<xref rid="bibr33-15347354211026757" ref-type="bibr">33</xref></sup></p>
                <p><italic toggle="yes">Qualitative Data Collection</italic> At the completion of the trial,
patients were asked to provide narrative responses to the open-ended questions,
“what do you like about the system,” “what do you dislike about the system,” and
“what can be improved?”</p>
              </sec>
              <sec id="section16-15347354211026757">
                <title>Data Analysis</title>
                <p>Prior to statistical analyses, data were examined for accuracy and completeness.
Kolmogorov-Smirnov test was used to identify whether the data fit a normal
distribution. Descriptive statistics were used to summarize study variables,
stratified by time-point of pre- and post- Kinect-TOLF intervention. Continuous
variables were summarized in terms of means, medians, standard deviations (SD),
ranges, and quantiles. Categorical variables were summarized using frequencies
and proportions. Confidence intervals were reported to quantify the precision of
estimates. The alpha level was set at .05 and 95% confidence intervals [CI] were
reported for all of the statistical tests when appropriate. We used R version
3.6.2 for all of the statistical analyses.</p>
                <p>For ordinal outcomes (i.e., lymphatic pain, hand/arm swelling) as well as for the
continuous outcome of total swelling, Wilcoxon signed-rank tests were performed
to test median differences in patients’ scores between pre- and post-
Kinect-TOLF intervention. Spearman’s rank correlation coefficients
(<italic toggle="yes">ρ<sub>Spearman</sub></italic>) were calculated to assess
whether pre-intervention symptom levels were associated with symptom change
scores for these outcomes. Effect sizes for each test were reported in the form
of Wilcoxon’s <italic toggle="yes">r</italic>.</p>
                <p>Changes in L-Dex values, the total number of symptoms and total symptom severity
scores were estimated using a simple linear regression of the difference between
the pre- and post-intervention values on the pre-intervention value (mean-centered).<sup><xref rid="bibr34-15347354211026757" ref-type="bibr">34</xref></sup> For each linear model, diagnostic plots were evaluated to ensure
statistical assumptions were met. The intercept in the model represents the mean
difference in patient outcomes between the pre-intervention values and the
slope. Significant intercept suggests a relationship between pre-intervention
values and the amount of within-person change observed at post-intervention
(e.g., patient with higher pre-intervention pain scores may experience a greater
degree of relief at post-intervention than patients with lower pain scores at
pre-intervention). We report Cohen’s <italic toggle="yes">d</italic> as an indicator of
effect size for mean differences.</p>
                <p>Qualitative data from the responses to the open-ended questions at the completion
of the trial were summarized thematically.<sup><xref rid="bibr2-15347354211026757" ref-type="bibr">2</xref>,<xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/>-<xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup> To ensure the credibility
of qualitative data analysis, we used a modified iterative 7-step descriptive
data analysis method<sup><xref rid="bibr2-15347354211026757" ref-type="bibr">2</xref>,<xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/>-<xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup> to
examine data, compare codes, challenge interpretations, and inductively develop
themes. First, the first author and other 2 authors read the qualitative data
independently several times to gain a broad understanding of the text. Second,
the 3 authors met as a group to identify key quotations and discuss key codes
related to the study. Third, the 3 authors combined the coded quotations into 1
file and confirmed the accuracy of the codes and quotations. Fourth, the 3
authors carefully analyzed quotation files and identifying major themes by
putting key coded quotations for each theme. Fifth, the 3 authors met as a group
to review major themes together and engaged in active dialogue to resolve any
discrepancies. Sixth, the 3 authors validated the structure of themes by
reviewing the qualitative data. Finally, the authors conducted multiple
discussions until consensus was achieved about the identified themes and each
aspect of the process of data analysis. Efforts were made to differentiate and
compare each theme with careful selection of quotations demonstrating the
essence of the study experience.<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/>-<xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup></p>
              </sec>
            </sec>
            <sec sec-type="results" id="section17-15347354211026757">
              <title>Results</title>
              <sec id="section18-15347354211026757">
                <title>Characteristics of the Patients</title>
                <p>A total of 30 patients completed the feasibility clinical trial. No injury or
safety issues occurred during the trial. The patients had a mean age of
61.7 years and a mean BMI of 28.4 kg/m<sup>2</sup>. Among these patients, 86.7 %
had a bachelor’s or graduate degree, 46.7% were married, 46.7% were employed,
and 46.7% lived alone (<xref rid="table2-15347354211026757" ref-type="table">Table 2</xref>).</p>
                <table-wrap position="float" id="table2-15347354211026757">
                  <label>Table 2.</label>
                  <caption>
                    <p>Demographic Characteristics of Patients (<italic toggle="yes">N</italic> = 30).</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_15347354211026757-table2" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <tbody>
                        <tr>
                          <td rowspan="2" colspan="1">Age in years</td>
                          <td rowspan="1" colspan="1">Mean (standard deviation [SD]; range)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">61.7 (9.77; 42-82)</td>
                        </tr>
                        <tr>
                          <td rowspan="2" colspan="1">Body mass index</td>
                          <td rowspan="1" colspan="1">Mean (standard deviation [SD]; range)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">28.4 (6.3; 21.6-42.6)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Ethnicity</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> White</td>
                          <td rowspan="1" colspan="1">15 (50)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Asian</td>
                          <td rowspan="1" colspan="1">5 (16.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Black or African-American</td>
                          <td rowspan="1" colspan="1">5 (16.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Hispanic</td>
                          <td rowspan="1" colspan="1">3 (10)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> More than 1 race</td>
                          <td rowspan="1" colspan="1">2 (6.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Highest level of education</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Partial college/professional school degree</td>
                          <td rowspan="1" colspan="1">4 (13.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Bachelor’s degree</td>
                          <td rowspan="1" colspan="1">17 (56.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Master’s/doctoral degree</td>
                          <td rowspan="1" colspan="1">9 (30)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Marital status</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Married</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Divorced/separated</td>
                          <td rowspan="1" colspan="1">6 (20)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Single, never married</td>
                          <td rowspan="1" colspan="1">10 (33.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Employment</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Working now</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Retired</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Looking for work, unemployed</td>
                          <td rowspan="1" colspan="1">2 (6.6)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Residence status</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Home-alone</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Home-family</td>
                          <td rowspan="1" colspan="1">16 (53.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Financial status</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Comfortable: have more than enough to make ends meet</td>
                          <td rowspan="1" colspan="1">11 (36.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Have enough to make ends meet</td>
                          <td rowspan="1" colspan="1">18 (60)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Do not have enough to make ends meet</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Smoking history</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Never smoked</td>
                          <td rowspan="1" colspan="1">22 (73.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Former (stopped more than 1 year before this
encounter)</td>
                          <td rowspan="1" colspan="1">8 (26.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Drinking habits</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Never</td>
                          <td rowspan="1" colspan="1">4 (13.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Fewer than 1 drink per week</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> 1 alcoholic drink per week</td>
                          <td rowspan="1" colspan="1">3 (10)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> 2-7 drinks per week</td>
                          <td rowspan="1" colspan="1">8 (26.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> 7 or more drinks per week</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>As shown in <xref rid="table3-15347354211026757" ref-type="table">Table 3</xref>,
43.3% of the patients had a lumpectomy, 60% had a mastectomy, 56.7% had breast
reconstruction, 83.3% had chemotherapy, and 90% had radiation therapy. While
23.3% of the patients underwent axillary lymph node dissection, 30% had only
sentinel lymph node biopsy. The mean number of lymph nodes removed was 11.4.
Fifty percent of the patients were diagnosed with and treated for lymphedema.
The mean years elapsed since the breast cancer diagnosis was 7.54 (SD = 6.24;
median = 5.16, range = 2-23 years). Among the 30 patients, 10 (33%) patients had
a L-Dex ratio ≥7.1 and 20 (67%) patients had a L-Dex ratio &lt;7.1.</p>
                <table-wrap position="float" id="table3-15347354211026757">
                  <label>Table 3.</label>
                  <caption>
                    <p>Clinical Characteristics of Patients (<italic toggle="yes">N</italic> = 30).</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_15347354211026757-table3" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <tbody>
                        <tr>
                          <td rowspan="1" colspan="1">Location of cancer</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Right breast</td>
                          <td rowspan="1" colspan="1">16 (53.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Left breast</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Sentinel lymph nodes biopsy</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">9 (30)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">21 (70)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Axillary lymph nodes dissection (ALND)</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">7 (23.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">23 (76.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Sentinel lymph nodes biopsy and ALND</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">15 (50)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">15 (50)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Mastectomy</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">18 (60)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">12 (40)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Lumpectomy</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">13 (43.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> NO</td>
                          <td rowspan="1" colspan="1">17 (56.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Breast reconstruction</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">17 (56.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">13 (43.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Being diagnosed with lymphedema</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">15 (50)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">15 (50)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Lymph fluid level by bioimpedance</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> L-Dex ratio &lt;7.1</td>
                          <td rowspan="1" colspan="1">20 (67)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> L-Dex ratio ≥7.1</td>
                          <td rowspan="1" colspan="1">10 (33)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Chemotherapy</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">25 (83.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">5 (16.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Radiation therapy</td>
                          <td rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Yes</td>
                          <td rowspan="1" colspan="1">27 (90)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> No</td>
                          <td rowspan="1" colspan="1">3 (10)</td>
                        </tr>
                        <tr>
                          <td rowspan="2" colspan="1">Number of lymph nodes removed</td>
                          <td rowspan="1" colspan="1">Mean (standard deviation; range)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">11.4 (9.1; 1 – 30)</td>
                        </tr>
                        <tr>
                          <td rowspan="2" colspan="1">Times since breast cancer diagnosis in
years</td>
                          <td rowspan="1" colspan="1">Mean/median (standard deviation; range)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">7.54/5.16 (6.24; 2–23)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="section19-15347354211026757">
                <title>Feasibility</title>
                <p>Feasibility of the study was demonstrated by timely study accrual (N = 30) in
less than 3 months, ahead of the planned 6 months recruitment. The study
achieved 100% protocol adherence with no patient withdrawal and protocol
deviation. Of the 50 patients who were eligible for the study, only 8 patients
declined the study without giving a reason. Twelve patients were eager but not
able to participate in the study due to unexpected family events, time
conflicts, and long-distance travel.</p>
              </sec>
              <sec id="section20-15347354211026757">
                <title>Usability</title>
                <p>Patients’ responses to questions regarding Nielson's heuristic
violations<sup><xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref><xref rid="bibr24-15347354211026757" ref-type="bibr"/>-<xref rid="bibr25-15347354211026757" ref-type="bibr">25</xref></sup> indicated
no major usability problems or usability catastrophe associated with the
Kinect-TOLF during the trial. Specifically, none of the 30 patients reported
major usability problems or usability catastrophes; 24 (80%) reported no
usability problem; 4 (13.3%) reported minor usability problems (ie, minor
mis-synchronization of the motion performed and what the screen displayed); and
2 (6.7%) reported cosmetic problem (ie, dislike the computer-generated voice and
display of the catalog of the exercises). The heuristic evaluation demonstrated
that the iterative process of refinement of the Kinect-TOLF was effective. By
the last 10 participants, no usability problems were reported.</p>
              </sec>
              <sec id="section21-15347354211026757">
                <title>Acceptance</title>
                <p><xref rid="table4-15347354211026757" ref-type="table">Table 4</xref> presents
detailed information about patients’ responses to <italic toggle="yes">The Perceived Ease of
Use and Usefulness Questionnaire.</italic><sup><xref rid="bibr28-15347354211026757" ref-type="bibr">28</xref>,<xref rid="bibr29-15347354211026757" ref-type="bibr">29</xref></sup> Over 90% of patients
strongly agreed or agreed that the Kinect-TOLF was easy to learn, and flexible
and easy to operate. Further, 93.4% of patients strongly agreed or agreed that
their interactions with the system were clear and understandable. Over 80% of
patients strongly agreed or agreed that the Kinect-TOLF made it easy for them to
remember how to perform the lymphatic exercises. <xref rid="table5-15347354211026757" ref-type="table">Table 5</xref> shows patients’ responses to
the <italic toggle="yes">Post Study System Usability Questionnaire.</italic><sup><xref rid="bibr30-15347354211026757" ref-type="bibr">30</xref></sup> Average ratings on all of the items ranged from 1.20 to 1.53 on a scale
that ranged from 1 (strongly agree) to 7 (strongly disagree), indicating that
participants strongly agreed or agreed on user satisfaction with the
Kinect-TOLF.</p>
                <table-wrap position="float" id="table4-15347354211026757">
                  <label>Table 4.</label>
                  <caption>
                    <p>The Perceived Ease of Use and Usefulness Questionnaire
(<italic toggle="yes">N</italic> = 30).</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_15347354211026757-table4" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Strongly agree <italic toggle="yes">n</italic> (%)</th>
                          <th align="center" rowspan="1" colspan="1">Agree <italic toggle="yes">n</italic> (%)</th>
                          <th align="center" rowspan="1" colspan="1">Neutral <italic toggle="yes">n</italic> (%)</th>
                          <th align="center" rowspan="1" colspan="1">Disagree <italic toggle="yes">n</italic> (%)</th>
                          <th align="center" rowspan="1" colspan="1">Strongly disagree <italic toggle="yes">n</italic> (%)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td rowspan="1" colspan="1">I find the system easy to use.</td>
                          <td rowspan="1" colspan="1">18 (60)</td>
                          <td rowspan="1" colspan="1">10 (33.3)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">0 (0)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Learning to operate or follow the system is easy for
me.</td>
                          <td rowspan="1" colspan="1">17 (56.7)</td>
                          <td rowspan="1" colspan="1">11 (36.7)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">0 (0)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Interaction with the system is difficult.</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">2 (6.7)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">13 (43.3)</td>
                          <td rowspan="1" colspan="1">13 (43.3)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">I find it easy to get the system to do what I want it to
do.</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                          <td rowspan="1" colspan="1">11 (36.7)</td>
                          <td rowspan="1" colspan="1">3 (10)</td>
                          <td rowspan="1" colspan="1">2 (6.7)</td>
                          <td rowspan="1" colspan="1">0 (0)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">The system is flexible to interact with.</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                          <td rowspan="1" colspan="1">13 (43.3)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">2 (6.7)</td>
                          <td rowspan="1" colspan="1">0 (0)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">It is easy for me to remember how to perform tasks using the
system.</td>
                          <td rowspan="1" colspan="1">14 (46.7)</td>
                          <td rowspan="1" colspan="1">12 (40)</td>
                          <td rowspan="1" colspan="1">3 (10)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">0 (0)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Interacting with the system requires a lot of mental
effort.</td>
                          <td rowspan="1" colspan="1">0 (0)</td>
                          <td rowspan="1" colspan="1">2 (6.7)</td>
                          <td rowspan="1" colspan="1">5 (16.7)</td>
                          <td rowspan="1" colspan="1">12 (40)</td>
                          <td rowspan="1" colspan="1">11 (36.7)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">My interaction with the system is clear and
understandable.</td>
                          <td rowspan="1" colspan="1">17 (56.7)</td>
                          <td rowspan="1" colspan="1">11 (36.7)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">1 (3.3)</td>
                          <td rowspan="1" colspan="1">0 (0)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <table-wrap position="float" id="table5-15347354211026757">
                  <label>Table 5.</label>
                  <caption>
                    <p>The Post-Study System Usability Questionnaire
(<italic toggle="yes">N</italic> = 30).</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_15347354211026757-table5" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Subscales</th>
                          <th align="center" rowspan="1" colspan="1">Items</th>
                          <th align="center" rowspan="1" colspan="1">Mean (SD)<sup><xref rid="table-fn1-15347354211026757" ref-type="table-fn">a</xref></sup></th>
                          <th align="center" rowspan="1" colspan="1">Median</th>
                          <th align="center" rowspan="1" colspan="1">Range<sup><xref rid="table-fn2-15347354211026757" ref-type="table-fn">b</xref></sup></th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td rowspan="6" colspan="1">System Usefulness</td>
                          <td rowspan="1" colspan="1">Overall, I am satisfied with how easy it is to use this
system.</td>
                          <td rowspan="1" colspan="1">1.4 (0.62)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-3</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">It was simple to use this system.</td>
                          <td rowspan="1" colspan="1">1.53 (0.82)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-4</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">I could effectively follow the system to learn how to
perform the lymphatic exercises.</td>
                          <td rowspan="1" colspan="1">1.23 (0.51)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-3</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">I felt comfortable using this system to learn how to perform
the lymphatic exercises.</td>
                          <td rowspan="1" colspan="1">1.33 (0.96)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-6</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">It was easy to learn the lymphatic exercises using this
system.</td>
                          <td rowspan="1" colspan="1">1.17 (0.46)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-3</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">I believe I could learn how to perform the lymphatic
exercises correctly using this system.</td>
                          <td rowspan="1" colspan="1">1.37 (0.99)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-6</td>
                        </tr>
                        <tr>
                          <td rowspan="3" colspan="1">Interface Quality</td>
                          <td rowspan="1" colspan="1">The system gave error messages that clearly told me how to
fix problems.</td>
                          <td rowspan="1" colspan="1">1.4 (0.81)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-5</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Whenever I made a mistake in performing the lymphatic
exercises, the system immediately told me so.</td>
                          <td rowspan="1" colspan="1">1.53 (0.82)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-4</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">The information (such as on-screen messages) provided with
this system was clear.</td>
                          <td rowspan="1" colspan="1">1.23 (0.5)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-3</td>
                        </tr>
                        <tr>
                          <td rowspan="4" colspan="1">Information quality</td>
                          <td rowspan="1" colspan="1">It was easy to follow the system to learn the correct way to
perform the lymphatic exercises.</td>
                          <td rowspan="1" colspan="1">1.53 (1.07)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-6</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">The information provided for the system was easy to
understand.</td>
                          <td rowspan="1" colspan="1">1.33 (0.55)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-3</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">The information was effective in helping me to learn to
correctly perform the lymphatic exercises.</td>
                          <td rowspan="1" colspan="1">1.2 (0.48)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-3</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">The organization of information on the system screens was
clear.</td>
                          <td rowspan="1" colspan="1">1.2 (0.5)</td>
                          <td rowspan="1" colspan="1">1</td>
                          <td rowspan="1" colspan="1">1-3</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="table-fn1-15347354211026757">
                      <label>a</label>
                      <p>SD: Standard Deviation.</p>
                    </fn>
                    <fn id="table-fn2-15347354211026757">
                      <label>b</label>
                      <p>On a scale of 1 to 7, 1 represents strongly agree and 7 represents
strongly disagree.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="section22-15347354211026757">
                <title>Effects of the Kinect-TOLF on Lymphatic Pain, Swelling, and Lymphedema
Symptoms</title>
                <sec id="section23-15347354211026757">
                  <title>Lymphatic pain and swelling</title>
                  <p><xref rid="table6-15347354211026757" ref-type="table">Table 6</xref> provides
the results of effects of the Kinect-TOLF on lymphatic pain, swelling, and
lymphedema symptoms. Significant reductions were found in lymphatic pain
(<italic toggle="yes">Med</italic><sub>Δ</sub> = −1.00, CI <italic toggle="yes">=</italic> [−1.5,
−0.1], <italic toggle="yes">P</italic> = .004), arm/hand swelling
(<italic toggle="yes">Med</italic><sub>Δ</sub> = −1.00, CI = [−1.5, −0.5],
<italic toggle="yes">P</italic> = .004), and total swelling scores
(<italic toggle="yes">Med</italic><sub>Δ</sub> = −1.5, CI = [−2.0, −1.0],
<italic toggle="yes">P</italic> = .003) scores. Spearman’s rank correlation
coefficients suggest that patients with higher pain scores at the
pre-intervention assessment had significantly greater decrease in pain
(<italic toggle="yes">ρ<sub>Spearman</sub></italic> <italic toggle="yes">=</italic> .49,
<italic toggle="yes">P</italic> <italic toggle="yes">=</italic> .006). Patients with greater
severity of arm/hand swelling at the pre-intervention assessment had a
significantly greater reduction in arm/hand swelling
(<italic toggle="yes">ρ<sub>Spearman</sub></italic> = .66,
<italic toggle="yes">P</italic> <italic toggle="yes">&lt;</italic> .0001). Greater severity of
total swelling at pre-intervention assessment was associated with greater
improvement (<italic toggle="yes">ρ<sub>Spearman</sub></italic> = .36,
<italic toggle="yes">P</italic> = .048).</p>
                  <table-wrap position="float" id="table6-15347354211026757">
                    <label>Table 6.</label>
                    <caption>
                      <p>Lymphatic Pain, Arm/Hand Swelling, Total Swelling, L-Dex, and Symptom
Occurrence and Severity.</p>
                    </caption>
                    <alternatives>
                      <graphic xlink:href="10.1177_15347354211026757-table6" position="float"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" rowspan="2" colspan="1">Outcome variables</th>
                            <th align="center" colspan="3" rowspan="1">Pre Kinect-TOLF</th>
                            <th align="center" colspan="3" rowspan="1">Post Kinect-TOLF</th>
                            <th align="center" colspan="4" rowspan="1">Change scores (post-pre
differences)</th>
                          </tr>
                          <tr>
                            <th align="center" rowspan="1" colspan="1">Med</th>
                            <th align="center" rowspan="1" colspan="1">IQR</th>
                            <th align="center" rowspan="1" colspan="1">Range</th>
                            <th align="center" rowspan="1" colspan="1">Med</th>
                            <th align="center" rowspan="1" colspan="1">IQR</th>
                            <th align="center" rowspan="1" colspan="1">Range</th>
                            <th align="center" rowspan="1" colspan="1">Med difference (95%CI)</th>
                            <th align="center" rowspan="1" colspan="1">Statistics</th>
                            <th align="center" rowspan="1" colspan="1">
                              <italic toggle="yes">P</italic>
                            </th>
                            <th align="center" rowspan="1" colspan="1">Effect Size (95%CI)</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td rowspan="1" colspan="1">Lymphatic limb pain</td>
                            <td rowspan="1" colspan="1">1</td>
                            <td rowspan="1" colspan="1">1</td>
                            <td rowspan="1" colspan="1">0-4</td>
                            <td rowspan="1" colspan="1">0</td>
                            <td rowspan="1" colspan="1">2</td>
                            <td rowspan="1" colspan="1">0-3</td>
                            <td rowspan="1" colspan="1">−1.0 (−1.5, −0.1)</td>
                            <td rowspan="1" colspan="1">−2.91<sup><xref rid="table-fn4-15347354211026757" ref-type="table-fn">a</xref></sup></td>
                            <td rowspan="1" colspan="1">.004</td>
                            <td rowspan="1" colspan="1">0.53 (0.25, 0.74)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Arm/hand swelling</td>
                            <td rowspan="1" colspan="1">1</td>
                            <td rowspan="1" colspan="1">2</td>
                            <td rowspan="1" colspan="1">0-4</td>
                            <td rowspan="1" colspan="1">0</td>
                            <td rowspan="1" colspan="1">1</td>
                            <td rowspan="1" colspan="1">0-3</td>
                            <td rowspan="1" colspan="1">−1.0 (−1.5, −0.5)</td>
                            <td rowspan="1" colspan="1">−2.92<sup><xref rid="table-fn4-15347354211026757" ref-type="table-fn">a</xref></sup></td>
                            <td rowspan="1" colspan="1">.004</td>
                            <td rowspan="1" colspan="1">0.54 (0.28, 0.71)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Total swelling</td>
                            <td rowspan="1" colspan="1">2</td>
                            <td rowspan="1" colspan="1">1.75</td>
                            <td rowspan="1" colspan="1">0-8</td>
                            <td rowspan="1" colspan="1">1</td>
                            <td rowspan="1" colspan="1">2</td>
                            <td rowspan="1" colspan="1">0-9</td>
                            <td rowspan="1" colspan="1">−1.5 (−2.0, −1.0)</td>
                            <td rowspan="1" colspan="1">−2.96<sup><xref rid="table-fn4-15347354211026757" ref-type="table-fn">a</xref></sup></td>
                            <td rowspan="1" colspan="1">.003</td>
                            <td rowspan="1" colspan="1">0.54 (0.26, 0.76)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">L-Dex</td>
                            <td rowspan="1" colspan="1">12.4</td>
                            <td rowspan="1" colspan="1">25.4</td>
                            <td rowspan="1" colspan="1">−7.2 to 108.1</td>
                            <td rowspan="1" colspan="1">9.7</td>
                            <td rowspan="1" colspan="1">24.6</td>
                            <td rowspan="1" colspan="1">−9.3 to 106.0</td>
                            <td rowspan="1" colspan="1">−2.7 (−4.7, −0.7)</td>
                            <td rowspan="1" colspan="1">−2.76<sup><xref rid="table-fn5-15347354211026757" ref-type="table-fn">b</xref></sup></td>
                            <td rowspan="1" colspan="1">.010</td>
                            <td rowspan="1" colspan="1">0.50<sup><xref rid="table-fn7-15347354211026757" ref-type="table-fn">d</xref></sup> (0.11, 0.89)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Number of symptoms</td>
                            <td rowspan="1" colspan="1">10.5</td>
                            <td rowspan="1" colspan="1">5.6</td>
                            <td rowspan="1" colspan="1">1-19</td>
                            <td rowspan="1" colspan="1">6.4</td>
                            <td rowspan="1" colspan="1">6.6</td>
                            <td rowspan="1" colspan="1">0-22</td>
                            <td rowspan="1" colspan="1">−3.8 (−5.5, −2.1)</td>
                            <td rowspan="1" colspan="1">−4.56<sup><xref rid="table-fn5-15347354211026757" ref-type="table-fn">b</xref></sup></td>
                            <td rowspan="1" colspan="1">&lt;.001</td>
                            <td rowspan="1" colspan="1">0.85<sup><xref rid="table-fn7-15347354211026757" ref-type="table-fn">d</xref></sup> (0.43, 1.29)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Symptom severity score</td>
                            <td rowspan="1" colspan="1">19.3</td>
                            <td rowspan="1" colspan="1">15.5</td>
                            <td rowspan="1" colspan="1">2-66</td>
                            <td rowspan="1" colspan="1">12.4</td>
                            <td rowspan="1" colspan="1">16.8</td>
                            <td rowspan="1" colspan="1">0-66</td>
                            <td rowspan="1" colspan="1">−5.3 (−9.5, −1.1)</td>
                            <td rowspan="1" colspan="1">−2.58<sup><xref rid="table-fn5-15347354211026757" ref-type="table-fn">b</xref></sup></td>
                            <td rowspan="1" colspan="1">.016</td>
                            <td rowspan="1" colspan="1">0.49<sup><xref rid="table-fn7-15347354211026757" ref-type="table-fn">d</xref></sup> (0.11, 0.88)</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                    <table-wrap-foot>
                      <fn id="table-fn3-15347354211026757">
                        <p>Abbreviation: Med, median; IQR, inter-quartile range; SD,
standard deviation.</p>
                      </fn>
                      <fn id="table-fn4-15347354211026757">
                        <label>a</label>
                        <p>Wilcoxon signed-rank test <italic toggle="yes">Z</italic>-Statistic.</p>
                      </fn>
                      <fn id="table-fn5-15347354211026757">
                        <label>b</label>
                        <p>Paired <italic toggle="yes">t</italic>-test <italic toggle="yes">t</italic>-statistic.</p>
                      </fn>
                      <fn id="table-fn6-15347354211026757">
                        <label>c</label>
                        <p>Wilcoxon’s <italic toggle="yes">r.</italic></p>
                      </fn>
                      <fn id="table-fn7-15347354211026757">
                        <label>d</label>
                        <p>Cohen’s <italic toggle="yes">d.</italic></p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
                <sec id="section24-15347354211026757">
                  <title>Lymphedema symptom occurrence and severity</title>
                  <p><xref rid="table7-15347354211026757" ref-type="table">Table 7</xref> presents
the occurrence of the 24 lymphedema symptoms before and after the
Kinect-TOLF intervention. Significant reductions were found in the total
number of lymphedema symptoms (<italic toggle="yes">M</italic><sub>Δ</sub> = −3.8,
CI = [−5.5, −2.1], <italic toggle="yes">P</italic> &lt; .001) and total symptom severity
scores (<italic toggle="yes">M</italic><sub>Δ</sub> = −5.3, CI = [−9.5, −1.1],
<italic toggle="yes">P</italic> = .016, <xref rid="table6-15347354211026757" ref-type="table">Table 6</xref>).</p>
                  <table-wrap position="float" id="table7-15347354211026757">
                    <label>Table 7.</label>
                    <caption>
                      <p>Lymphedema Symptom Occurrence Pre- and Post- Kinect-TOLF
Intervention.</p>
                    </caption>
                    <alternatives>
                      <graphic xlink:href="10.1177_15347354211026757-table7" position="float"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" span="1"/>
                          <col align="char" char="." span="1"/>
                          <col align="char" char="." span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="left" rowspan="2" colspan="1">Symptoms</th>
                            <th align="center" rowspan="1" colspan="1">Pre-Kinect-TOLF</th>
                            <th align="center" rowspan="1" colspan="1">Post-Kinect-TOLF</th>
                          </tr>
                          <tr>
                            <th align="center" rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</th>
                            <th align="center" rowspan="1" colspan="1"><italic toggle="yes">n</italic> (%)</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td rowspan="1" colspan="1">Lymphatic pain (ie, pain/aching/soreness in the affected
limb or body side)</td>
                            <td rowspan="1" colspan="1">24 (80.0)</td>
                            <td rowspan="1" colspan="1">12 (40.0)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Arm/hand swelling</td>
                            <td rowspan="1" colspan="1">21 (70.0)</td>
                            <td rowspan="1" colspan="1">14 ( 46.67)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Breast swelling</td>
                            <td rowspan="1" colspan="1">11 (36.7)</td>
                            <td rowspan="1" colspan="1">7 (23.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Chest wall swelling</td>
                            <td rowspan="1" colspan="1">9 (30.0)</td>
                            <td rowspan="1" colspan="1">5 (16.7)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Limited movement in the affected shoulder</td>
                            <td rowspan="1" colspan="1">15 (50.0)</td>
                            <td rowspan="1" colspan="1">12 (40.0)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Limited movement in the affected elbow</td>
                            <td rowspan="1" colspan="1">8 (26.7)</td>
                            <td rowspan="1" colspan="1">6 (20)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Limited movement in the affected wrist</td>
                            <td rowspan="1" colspan="1">6 (20.0)</td>
                            <td rowspan="1" colspan="1">7 (23.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Limited movement in the affected fingers</td>
                            <td rowspan="1" colspan="1">11 (36.7)</td>
                            <td rowspan="1" colspan="1">7 (23.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Limited movement in the affected arm</td>
                            <td rowspan="1" colspan="1">21 (70.0)</td>
                            <td rowspan="1" colspan="1">13 (43.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Arm firmness</td>
                            <td rowspan="1" colspan="1">21 (70.0)</td>
                            <td rowspan="1" colspan="1">8 (26.7)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Arm tightness</td>
                            <td rowspan="1" colspan="1">24 (80.0)</td>
                            <td rowspan="1" colspan="1">16 (53.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Arm heaviness</td>
                            <td rowspan="1" colspan="1">21 (70.0)</td>
                            <td rowspan="1" colspan="1">13 (43.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Fibrosis (ie, toughness or thickness of skin in the
affected limb)</td>
                            <td rowspan="1" colspan="1">9 (30.0)</td>
                            <td rowspan="1" colspan="1">7 (23.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Stiffness in the affected limb</td>
                            <td rowspan="1" colspan="1">21 (70.0)</td>
                            <td rowspan="1" colspan="1">13 (43.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Tenderness in the affected limb</td>
                            <td rowspan="1" colspan="1">17 (56.7)</td>
                            <td rowspan="1" colspan="1">7 (23.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Hotness/increased temperature in the affected limb</td>
                            <td rowspan="1" colspan="1">7 (23.3)</td>
                            <td rowspan="1" colspan="1">3 (10.0)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Redness in the affected limb</td>
                            <td rowspan="1" colspan="1">2 (6.7)</td>
                            <td rowspan="1" colspan="1">2 (6.7)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Blistering in the affected limb</td>
                            <td rowspan="1" colspan="1">1 (3.3)</td>
                            <td rowspan="1" colspan="1">1 (3.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Numbness in the affected limb</td>
                            <td rowspan="1" colspan="1">15 (50.0)</td>
                            <td rowspan="1" colspan="1">12 (40.0)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Burning in the affected limb</td>
                            <td rowspan="1" colspan="1">5 (16.7)</td>
                            <td rowspan="1" colspan="1">3 (10.0)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Stabbing in the affected limb</td>
                            <td rowspan="1" colspan="1">6 (20.0)</td>
                            <td rowspan="1" colspan="1">4 (13.3)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Tingling (pins and needles) in the affected limb</td>
                            <td rowspan="1" colspan="1">15 (50.0)</td>
                            <td rowspan="1" colspan="1">9 (30.0)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Limb fatigue or weakness</td>
                            <td rowspan="1" colspan="1">18 (60.0)</td>
                            <td rowspan="1" colspan="1">14 (46.7)</td>
                          </tr>
                          <tr>
                            <td rowspan="1" colspan="1">Seroma (pocket of fluid developed)</td>
                            <td rowspan="1" colspan="1">7 (23.3)</td>
                            <td rowspan="1" colspan="1">4 (13.3)</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                  </table-wrap>
                </sec>
                <sec id="section25-15347354211026757">
                  <title>Lymph fluid level by bioimpedance</title>
                  <p>A significant reduction in lymph fluid levels was found based on mean L-Dex
scores (<italic toggle="yes">M</italic><sub>Δ</sub> = −2.68, CI = [−4.67, −0.69],
<italic toggle="yes">P</italic> = .010). Higher reductions in mean L-Dex scores were
observed in the 10 patients who had abnormal lymph fluid level (ie, L-Dex of
≥7.1) at pre-intervention assessment
(<italic toggle="yes">M</italic><sub>Δ</sub> = −5.19, CI = [−1.75, −8.63],
<italic toggle="yes">P</italic> = .008).</p>
                </sec>
              </sec>
              <sec id="section26-15347354211026757">
                <title>Qualitative Results</title>
                <p>Five main themes emerged from the qualitative data, namely: standardized learning
for lymphatic exercises; having a control over the training; effectiveness of
the training; effectiveness of the lymphatic exercises; and easy to use. <xref rid="table8-15347354211026757" ref-type="table">Table 8</xref> provides
representative quotes for each of the theme.</p>
                <table-wrap position="float" id="table8-15347354211026757">
                  <label>Table 8.</label>
                  <caption>
                    <p>Themes and Representative Quotes from Qualitative Evaluation
(<italic toggle="yes">N</italic> = 30).</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_15347354211026757-table8" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                      </colgroup>
                      <tbody>
                        <tr>
                          <td rowspan="1" colspan="1">Providing a standardized format for lymphatic exercises</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">• “The model is easy to follow &amp; gives a standardized
format for proper maneuvers.”<break/>• “It is very helpful
in ensuring one does the exercises properly. Additionally,
the feedback is very helpful.”</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Having a control over the training</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">• “I had control over the exercises and could repeat them if
I did not perform them well.”<break/>• “Ability to follow
along independently.”</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Effectiveness of training</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">• “It really clearly showed me how to do the exercises and
where I was making errors.”<break/>• “The exercises were
thoroughly explained: Not only the how but the why. The
feedback was immediate so you can clearly tell if you were
doing them correctly.”<break/>• “I like the fact that it
tells you if you are doing the exercises
correctly.”<break/>• “I like the correction when I do the
exercise. Now, I know how to do this
correctly.”<break/>• “It really help me to adjust into
correct position of my shoulder (a difficult task for
me).”<break/>• “It is very helpful in ensuring one does the
exercises properly. Additionally, the feedback is very
helpful.”<break/>• “Step by step instructions on each
exercise and its immediate feedback.”<break/>• “Exercises
were clearly explained. Illustrations also clear. Immediate
feedback helpful.”<break/>• “The interaction with the model
and viewing my own body at the same time was
fun.”<break/>• “I like everything about it, I think the
system as a whole is quite perfunctory. I think it is a
well-designed system for someone living with lymphedema such
as me.”</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Effectiveness of the lymphatic exercises</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">• “I think it’s great and effective. I can feel the positive
difference within minutes of doing the
exercises.”<break/>• “I am more than satisfied because the
movements help me to stretch out tightness and relieve
pain.”<break/>• “I like it. For breast cancer survivors, we
can follow the program and see the videos that are easy to
follow with no problem. Good for practicing
exercises.”<break/>• “The exercises are very
helpful.”<break/>• “Useful exercises.”</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Ease of use</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">• “It is good and easy to follow and I like it that is shows
how you are breathing etc.”<break/>• “Easy to use and
immediate feedback was given.”<break/>• “It was easy to
follow.”<break/>• “I like everything, it was pretty
straightforward.”</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>The most salient theme was that patients felt that the Kinect-TOLF was effective
in teaching them how to do the lymphatic exercises correctly by providing them
with a standardized format for each exercise that was “easy to follow.” Patients
appreciated that the Kinect-TOLF provided immediate feedback on “where [they
were] making errors.” As 1 patient remarked, the Kinect-TOLF helped her to
adjust her shoulder to the correct position for the exercises, which is a
“difficult task for me.” Patients noted that the Kinect-TOLF increased their
sense of self-efficacy because the program allowed them to learn and perform the
exercises independently and that they could repeat them as often as they wanted
to do so. Patients felt that the lymphatic exercises had immediate effects to
“stretch out tightness and relieve pain,” and have a “positive difference within
minutes of doing the exercises.” Finally, patients concluded that the
Kinect-TOLF was “easy to use” and “straightforward.”</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="section27-15347354211026757">
              <title>Discussion</title>
              <p>The efficacy of self-care exercise interventions relies on accurate body movements.
Findings from this study demonstrated that the Kinect-TOLF intervention is feasible
and efficacious in training patients to perform lymphatic exercises accurately.
Feasibility of the study was supported by 100% of study accrual ahead of time (i.e.,
more than 3 months ahead of the planned 6 months of recruitment) and 100% of
protocol adherence without any protocol deviation and patient withdrawal from the
study. The majority of our patients reported no usability problems and agreed that
the system was easy to learn and operate, flexible to use, clear, and
understandable. As expected, some patients reported that it took a lot of mental
effort to learn the lymphatic exercises. However, over 80% of them indicated that
the Kinect-TOLF made it easy for them to remember how to correctly perform the
exercises. Nearly every patient expressed how much they appreciated the real-time
feedback, which enabled them to perform each exercise correctly. Overall, our
findings provide preliminary evidence that the Kinect-TOLF is a simple and
efficacious system that patients can use to learn self-care therapeutic exercises
correctly.</p>
              <p>The goal of the TOLF lymphatic exercises is to relieve lymphatic pain, swelling, and
lymphedema symptoms.<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref>,<xref rid="bibr18-15347354211026757" ref-type="bibr">18</xref></sup> In face-to-face<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref></sup> and avatar-based coaching<sup><xref rid="bibr18-15347354211026757" ref-type="bibr">18</xref></sup> studies, the TOLF intervention was safe, feasible, and efficacious in
relieving lymphatic pain and reducing lymphedema symptoms as well as in decreasing
the risk of objective lymph fluid accumulation by limb volume using infrared
perometer. The current study extends these findings and suggests that the
Kinect-TOLF is safe, feasible, and have immediate effects on lymphatic pain,
swelling, lymphedema symptoms, and lymph fluid level after a single training session
of the Kinect-TOLF. Significant reductions were found in lymphatic pain
(<italic toggle="yes">P</italic> = .004), arm/hand swelling (<italic toggle="yes">P</italic> = .004),
total swelling (<italic toggle="yes">P</italic> = .003), number of lymphedema symptoms
(<italic toggle="yes">P</italic> &lt; .001), and symptom severity scores
(<italic toggle="yes">P</italic> = .016). In addition, patients who had the greatest severity of
lymphatic pain, arm/hand swelling, and total swelling prior to intervention had the
greatest improvements in these symptoms. Taken together, these findings suggest that
the effects of a single session of Kinect-TOLF intervention were immediate to
relieve lymphatic pain, arm/hand swelling, total swelling, and lymphedema symptoms.
Patients’ immediate therapeutic responses are also supported by the qualitative
data. Patients reported positive effects within minutes of performing the lymphatic
exercises. These perceptions of immediate effects of the Kinect-TOLF are important
because sustained behavior change is more easily maintained if patients perceive
that an intervention is effective and easy to integrate into their daily lives.<sup><xref rid="bibr35-15347354211026757" ref-type="bibr">35</xref></sup></p>
              <p>The TOLF lymphatic exercises were designed to decrease lymph fluid levels.<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref>,<xref rid="bibr18-15347354211026757" ref-type="bibr">18</xref></sup> In a previous study,<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref></sup> 97% of the 134 patients who received the face-to-face TOLF intervention
maintained or decreased their preoperative limb volumes assessed using an infrared
perometer at 12 months after surgery. In the current study, all of the patients had
significant reductions in lymph fluid levels assessed using bioimpedance immediately
after a single training session of Kinect-TOLF. In addition, greater reductions in
lymph fluid levels were found in patients with abnormal lymph fluid levels (i.e.,
their scores decreased by 5.1 points). Given these results, it is reasonable to
hypothesize that daily or weekly use of the Kinect-TOLF intervention may help
patients to achieve normal lymph fluid levels.</p>
            </sec>
            <sec id="section28-15347354211026757">
              <title>Efforts to Prevent Bias</title>
              <p>To prevent recruitment bias, patients were recruited from among the
consecutively-identified breast cancer patients who reported persistent lymphatic
pain or lymphedema symptoms in the ipsilateral upper limb or body at least 12 weeks
after breast cancer surgery during routine clinical visit. In addition, the
technology-enhanced Kinect-TOLF system ensured the fidelity of intervention
delivery.</p>
            </sec>
            <sec id="section29-15347354211026757">
              <title>Strengths and Limitations of the Study</title>
              <p>The strengths of this trial include the use of a well-designed Kinect-enhanced
training system<sup><xref rid="bibr20-15347354211026757" ref-type="bibr">20</xref><xref rid="bibr21-15347354211026757" ref-type="bibr"/>-<xref rid="bibr22-15347354211026757" ref-type="bibr">22</xref></sup> based on an
evidence-based effective intervention;<sup><xref rid="bibr17-15347354211026757" ref-type="bibr">17</xref><xref rid="bibr18-15347354211026757" ref-type="bibr"/>-<xref rid="bibr19-15347354211026757" ref-type="bibr">19</xref></sup> an adequate sample size for
feasibility<sup><xref rid="bibr26-15347354211026757" ref-type="bibr">26</xref>,<xref rid="bibr27-15347354211026757" ref-type="bibr">27</xref></sup> and usability testing;<sup><xref rid="bibr23-15347354211026757" ref-type="bibr">23</xref>,<xref rid="bibr24-15347354211026757" ref-type="bibr">24</xref></sup> and the use of both objective
and subjective measures for efficacy testing. While not a randomized trial, this
study provides an effect size for each outcome variable for future trials. As
Kinect-TOLF lymphatic exercises can be used alone or as an adjuvant therapy to
current lymphedema treatment (e.g., compression therapy, manual lymph drainage, or
other forms of exercises), a randomized clinical trial with a larger sample is
warranted to confirm the unique or synergistic efficacy of the Kinect-TOLF in
comparison to current lymphedema treatment and other forms of exercises or movement
therapy. Future studies should also consider what constitutes a clinically
meaningful difference in using the Kinect-TOLF to reduce lymphatic pain, swelling,
lymphedema symptoms, and decrease lymph fluid levels. In terms of limitations,
patients were highly educated and had familiarity with computers and mobile
devices.</p>
            </sec>
            <sec sec-type="conclusions" id="section30-15347354211026757">
              <title>Conclusion</title>
              <p>The Kinect-TOLF is an easy-to-use, low-cost intervention that enables patients to
perform the therapeutic lymphatic exercises in a standardized way. This intelligent
Kinect-enhanced lymphatic exercise intervention enhances intervention fidelity and
insures that each patient receives the same quality of intervention. Importantly,
findings from this study suggest that a single session of Kinect-TOLF intervention
immediately reduces lymphatic pain, swelling, and lymphedema symptoms, as well as
decreases lymph fluid levels. The findings of this study should be further evaluated
in a large randomized clinical trial. If the results are replicated, the Kinect-TOLF
intervention will be relatively easy to implement in clinical practice or at home to
relieve lymphatic pain, swelling, and lymphedema symptoms, as well as to decrease
lymph fluid level, ultimately to improve the QOL of breast cancer survivors.</p>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank Ms. Alejandra Yancey for helping manage the trial and data collection. We
thank all the patients who participated in the trial. We thank nurses, physicians,
and staff at NYU Perlmutter Cancer Center for their support of the trial.</p>
            </ack>
            <fn-group>
              <fn fn-type="con">
                <p><bold>Author Contributions:</bold> The “Author Contributions” section should be completed as follow: (1) Conception
and design: Mei R. Fu, Yao Wang; (2) Administrative support: Mei R. Fu, Yao
Wang, Deborah Axelrod, Amber A. Guth, Zhipeng Fan; (3) Provision of study
material or patients: Mei R Fu, Deborah Axelrod, Amber A. Guth; (4) Collection
and assembly of data: Mei R. Fu, Eunjung Ko, Simay Yazicioglu, Jeanna M. Qiu,
Anna Sang; (5) Data analysis and interpretation: Mei R. Fu, Melissa McTernan,
Jeanna M. Qiu; (6) Manuscript Drafting: Mei R Fu, Jeanna M. Qiu, and Melissa
McTernan; (7) Manuscript revision and editing: All authors. (8) Final approval
of manuscript: All authors.</p>
              </fn>
              <fn fn-type="COI-statement">
                <p><bold>Declaration of Conflicting Interests:</bold> The author(s) declared no potential conflicts of interest with respect to the
research, authorship, and/or publication of this article.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: This study was
supported by the National Institute of Health /National Science Foundation
/National Cancer Institute (1R01CA214085-01) with Mei R Fu and Yao Wang as the
multiple principal investigators. This study was also supported by a research
grant from Judges and Lawyers Breast Cancer Alert with Mei R Fu as the principal
investigator. Its contents are solely the responsibility of the authors and do
not necessarily represent the official views of the funders. The funders had no
role in the study design, data collection and analysis, decision to publish, or
preparation of the manuscript.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>Human and Animal Rights and Informed Consent:</bold> This study (IRB # (S19-00222) was approved by the Institutional Review Board of a
metropolitan cancer center in New York of the United States. All the human
participants signed the informed consent. This study does not contain any animal
subjects.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>ORCID iDs:</bold> Mei R. Fu <inline-graphic xlink:href="10.1177_15347354211026757-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0003-3891-0109" ext-link-type="uri">https://orcid.org/0000-0003-3891-0109</ext-link></p>
                <p>Melissa L. McTernan <inline-graphic xlink:href="10.1177_15347354211026757-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0002-5151-8307" ext-link-type="uri">https://orcid.org/0000-0002-5151-8307</ext-link></p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="bibr1-15347354211026757">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burckhardt</surname><given-names>CS</given-names></name><name><surname>Jones</surname><given-names>KD.</given-names></name></person-group><article-title>Effects of chronic widespread pain on the health status and
quality of life of women after breast cancer surgery</article-title>.
<source>Health Qual Life Outcomes</source>.
<year>2005</year>;<volume>3</volume>(<issue>30</issue>):<fpage>1</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">15634354</pub-id></mixed-citation>
              </ref>
              <ref id="bibr2-15347354211026757">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degnim</surname><given-names>AC</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Hoskin</surname><given-names>TL</given-names></name></person-group>, <etal>et al</etal>. <article-title>A prospective study of
breast lymphedema: frequency, symptoms, and quality of life</article-title>.
<source>Breast Cancer Res Treat</source>.
<year>2012</year>;<volume>134</volume>:<fpage>915</fpage>-<lpage>922</lpage>.<pub-id pub-id-type="pmid">22415476</pub-id></mixed-citation>
              </ref>
              <ref id="bibr3-15347354211026757">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eaton</surname><given-names>LH</given-names></name><name><surname>Narkthong</surname><given-names>N</given-names></name><name><surname>Hulett</surname><given-names>JM</given-names></name></person-group>. <article-title>Psychosocial issues associated with breast
cancer-related lymphedema: a literature review</article-title>. <source>Curr
Breast Cancer Rep</source>.
<year>2020</year>:<fpage>1</fpage>-<lpage>9</lpage>.
doi:10.1007/s12609-020-00376-x</mixed-citation>
              </ref>
              <ref id="bibr4-15347354211026757">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanton</surname><given-names>AW</given-names></name><name><surname>Modi</surname><given-names>S</given-names></name><name><surname>Mellor</surname><given-names>RH</given-names></name><name><surname>Levick</surname><given-names>JR</given-names></name><name><surname>Mortimer</surname><given-names>PS.</given-names></name></person-group><article-title>Recent advances in breast cancer-related lymphedema of the arm:
lymphatic pump failure and predisposing factors</article-title>.
<source>Lymphat Res Biol</source>.
<year>2009</year>;<volume>7</volume>:<fpage>29</fpage>-<lpage>45</lpage>.<pub-id pub-id-type="pmid">19302022</pub-id></mixed-citation>
              </ref>
              <ref id="bibr5-15347354211026757">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helyer</surname><given-names>LK</given-names></name><name><surname>Varnic</surname><given-names>M</given-names></name><name><surname>Le</surname><given-names>LW</given-names></name><name><surname>Leong</surname><given-names>W</given-names></name><name><surname>McCready</surname><given-names>D.</given-names></name></person-group><article-title>Obesity is a risk factor for developing postoperative lymphedema
in breast cancer patients</article-title>. <source>Breast J</source>.
<year>2010</year>;<volume>16</volume>:<fpage>48</fpage>-<lpage>54</lpage>.<pub-id pub-id-type="pmid">19889169</pub-id></mixed-citation>
              </ref>
              <ref id="bibr6-15347354211026757">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>RJ</given-names></name><name><surname>Dennis</surname><given-names>LK</given-names></name><name><surname>Lynch</surname><given-names>CF</given-names></name><name><surname>Snetselaar</surname><given-names>LG</given-names></name><name><surname>Zamba</surname><given-names>GK</given-names></name><name><surname>Scott-Conner</surname><given-names>C.</given-names></name></person-group><article-title>The risk of developing arm lymphedema among breast cancer
survivors: a meta-analysis of treatment factors</article-title>. <source>Ann
Surg Oncol</source>.
<year>2009</year>;<volume>16</volume>:<fpage>1959</fpage>-<lpage>1972</lpage>.<pub-id pub-id-type="pmid">19365624</pub-id></mixed-citation>
              </ref>
              <ref id="bibr7-15347354211026757">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>MR</given-names></name><name><surname>Axelrod</surname><given-names>D</given-names></name><name><surname>Cleland</surname><given-names>CM</given-names></name></person-group>, <etal>et al</etal>. <article-title>Symptom reporting in
detecting breast cancer-related lymphedema</article-title>. <source>Breast
Cancer (Dove Med Press)</source>.
<year>2015</year>;<volume>7</volume>:<fpage>345</fpage>-<lpage>352</lpage>.<pub-id pub-id-type="pmid">26527899</pub-id></mixed-citation>
              </ref>
              <ref id="bibr8-15347354211026757">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>MR</given-names></name><name><surname>Aouizerat</surname><given-names>BE</given-names></name><name><surname>Yu</surname><given-names>G</given-names></name></person-group>, <etal>et al</etal>. <article-title>Model-based patterns of
lymphedema symptomology: phenotypic and biomarker
characterization</article-title>. <source>Curr Breast Cancer Rep</source>.
<year>2021</year>;<volume>13</volume>:<fpage>1</fpage>-<lpage>18</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr9-15347354211026757">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>MR</given-names></name><name><surname>Conley</surname><given-names>YP</given-names></name><name><surname>Axelrod</surname><given-names>D</given-names></name></person-group>, <etal>et al</etal>. <article-title>Precision assessment of
heterogeneity of lymphedema phenotype, genotypes and risk
prediction</article-title>. <source>Breast</source>.
<year>2016</year>;<volume>29</volume>:<fpage>231</fpage>-<lpage>240</lpage>.<pub-id pub-id-type="pmid">27460425</pub-id></mixed-citation>
              </ref>
              <ref id="bibr10-15347354211026757">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglass</surname><given-names>J</given-names></name><name><surname>Graves</surname><given-names>P</given-names></name><name><surname>Gordon</surname><given-names>S.</given-names></name></person-group><article-title>Self-care for management of secondary lymphedema: a systematic
review</article-title>. <source>PLoS Negl Trop Dis</source>.
<year>2016</year>;<volume>10</volume>:e0004740.</mixed-citation>
              </ref>
              <ref id="bibr11-15347354211026757">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armer</surname><given-names>JA</given-names></name><name><surname>Ostby</surname><given-names>P</given-names></name><name><surname>Ginex</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>. <article-title>ONS Guidelines for Cancer
treatment-related lymphedema</article-title>. <source>Oncol Nurs
Forum</source>.
<year>2020</year>;<volume>47</volume>:<fpage>518</fpage>-<lpage>538</lpage>.<pub-id pub-id-type="pmid">32830794</pub-id></mixed-citation>
              </ref>
              <ref id="bibr12-15347354211026757">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>MI</given-names></name><name><surname>Bagnall</surname><given-names>AM</given-names></name><name><surname>José Closs</surname><given-names>J.</given-names></name></person-group><article-title>How effective are patient-based educational interventions in the
management of cancer pain? Systematic review and
meta-analysis</article-title>. <source>Pain</source>.
<year>2009</year>;<volume>143</volume>:<fpage>192</fpage>-<lpage>199</lpage>.<pub-id pub-id-type="pmid">19285376</pub-id></mixed-citation>
              </ref>
              <ref id="bibr13-15347354211026757">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somers</surname><given-names>TJ</given-names></name><name><surname>Kelleher</surname><given-names>SA</given-names></name><name><surname>Dorfman</surname><given-names>CS</given-names></name></person-group>, <etal>et al</etal>. <article-title>An mhealth pain coping
skills training intervention for hematopoietic stem cell transplantation
patients: development and pilot randomized controlled trial</article-title>.
<source>JMIR Mhealth Uhealth</source>.
<year>2018</year>;<volume>6</volume>:<fpage>e66</fpage>.<pub-id pub-id-type="pmid">29555620</pub-id></mixed-citation>
              </ref>
              <ref id="bibr14-15347354211026757">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Groef</surname><given-names>A</given-names></name><name><surname>Van Kampen</surname><given-names>M</given-names></name><name><surname>Dieltjens</surname><given-names>E</given-names></name></person-group>, <etal>et al</etal>. <article-title>Effectiveness of
postoperative physical therapy for upper-limb impairments after breast
cancer treatment: a systematic review</article-title>. <source>Arch Phys Med
Rehabil</source>.
<year>2015</year>;<volume>96</volume>:<fpage>1140</fpage>-<lpage>1153</lpage>.<pub-id pub-id-type="pmid">25595999</pub-id></mixed-citation>
              </ref>
              <ref id="bibr15-15347354211026757">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zengin Alpozgen</surname><given-names>A</given-names></name><name><surname>Razak Ozdincler</surname><given-names>A</given-names></name><name><surname>Karanlik</surname><given-names>H</given-names></name><name><surname>Yaman Agaoglu</surname><given-names>F</given-names></name><name><surname>Narin</surname><given-names>AN</given-names></name></person-group>. <article-title>Effectiveness of pilates-based exercises on
upper extremity disorders related with breast cancer
treatment</article-title>. <source>Eur J Cancer Care (Engl)</source>.
<year>2017</year>;<volume>26</volume>:<fpage>1</fpage>-<lpage>8</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr16-15347354211026757">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galiano-Castillo</surname><given-names>N</given-names></name><name><surname>Cantarero-Villanueva</surname><given-names>I</given-names></name><name><surname>Fernández-Lao</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>Telehealth system: a
randomized controlled trial evaluating the impact of an internet-based
exercise intervention on quality of life, pain, muscle strength, and fatigue
in breast cancer survivors</article-title>. <source>Cancer</source>.
<year>2016</year>;<volume>122</volume>:<fpage>3166</fpage>-<lpage>3174</lpage>.<pub-id pub-id-type="pmid">27332968</pub-id></mixed-citation>
              </ref>
              <ref id="bibr17-15347354211026757">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>MR</given-names></name><name><surname>Axelrod</surname><given-names>D</given-names></name><name><surname>Guth</surname><given-names>AA</given-names></name></person-group>, <etal>et al</etal>. <article-title>Proactive approach to
lymphedema risk reduction: a prospective study</article-title>. <source>Ann
Surg Oncol</source>.
<year>2014</year>;<volume>21</volume>:<fpage>3481</fpage>-<lpage>3489</lpage>.<pub-id pub-id-type="pmid">24809302</pub-id></mixed-citation>
              </ref>
              <ref id="bibr18-15347354211026757">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>MR</given-names></name><name><surname>Axelrod</surname><given-names>D</given-names></name><name><surname>Guth</surname><given-names>AA</given-names></name></person-group>, <etal>et al</etal>. <article-title>mHealth self-care
interventions: managing symptoms following breast cancer
treatment</article-title>. <source>Mhealth</source>.
<year>2016</year>;<volume>2</volume>:<fpage>28</fpage>.<pub-id pub-id-type="pmid">27493951</pub-id></mixed-citation>
              </ref>
              <ref id="bibr19-15347354211026757">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>MR</given-names></name><name><surname>Axelrod</surname><given-names>D</given-names></name><name><surname>Guth</surname><given-names>AA</given-names></name></person-group>, <etal>et al</etal>. <article-title>Usability and feasibility of
health IT interventions to enhance self-care for lymphedema symptom
management in breast cancer survivors</article-title>. <source>Internet
Interv</source>.
<year>2016</year>;<volume>5</volume>:<fpage>56</fpage>-<lpage>64</lpage>.<pub-id pub-id-type="pmid">28255542</pub-id></mixed-citation>
              </ref>
              <ref id="bibr20-15347354211026757">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>AT</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>MR.</given-names></name></person-group><article-title>Kinect-based in-home exercise system for lymphatic health and
lymphedema intervention</article-title>. <source>IEEE J Transl Eng Health
Med</source>. <year>2018</year>;<volume>6</volume>:4100313.</mixed-citation>
              </ref>
              <ref id="bibr21-15347354211026757">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>AT</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>MR.</given-names></name></person-group><article-title>Motion sequence alignment for a Kinect based in-home exercise
system for lymphatic health and lymphedema intervention</article-title>.
<source>Annu Int Conf IEEE Eng Med Biol Soc</source>.
<year>2018</year>;<volume>2018</volume>:<fpage>2072</fpage>-<lpage>2075</lpage>.<pub-id pub-id-type="pmid">30440810</pub-id></mixed-citation>
              </ref>
              <ref id="bibr22-15347354211026757">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname><given-names>AT</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>M.</given-names></name></person-group><article-title>Denoising of joint tracking data by Kinect sensors using
clustered Gaussian process regression</article-title>.
<source>MMHealth17</source>.
<year>2017</year>;<volume>2017</volume>:<fpage>19</fpage>-<lpage>25</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr23-15347354211026757">
                <label>23</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kreuter</surname><given-names>M</given-names></name><name><surname>Farrell</surname><given-names>D</given-names></name><name><surname>Olevitch</surname><given-names>L</given-names></name><name><surname>Brennan</surname><given-names>L.</given-names></name></person-group><source>Tailoring Health Messages: Customizing Communication with Computer
Technology</source>. <edition>1st ed</edition>. <publisher-name>Lawrence
Erlbaum Associates, Inc.</publisher-name>;
<year>2000</year>.</mixed-citation>
              </ref>
              <ref id="bibr24-15347354211026757">
                <label>24</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>J</given-names></name><name><surname>Mack</surname><given-names>RL.</given-names></name></person-group><source>Usability Inspection Methods</source>. <edition>1st ed</edition>.
<publisher-name>Wiley</publisher-name>; <year>1994</year>.</mixed-citation>
              </ref>
              <ref id="bibr25-15347354211026757">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bright</surname><given-names>TJ</given-names></name><name><surname>Bakken</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>SB</given-names></name></person-group>. <article-title>Heuristic evaluation of eNote: an electronic
notes system</article-title>. <source>AMIA Annu Symp Proc</source>.
<year>2006</year>;<volume>2006</volume>:<fpage>864</fpage>.</mixed-citation>
              </ref>
              <ref id="bibr26-15347354211026757">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>RH.</given-names></name></person-group><article-title>On the use of a pilot sample for sample size
determination</article-title>. <source>Stat Med</source>.
<year>1995</year>;<volume>14</volume>:<fpage>1933</fpage>-<lpage>1940</lpage>.<pub-id pub-id-type="pmid">8532986</pub-id></mixed-citation>
              </ref>
              <ref id="bibr27-15347354211026757">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billingham</surname><given-names>AAM</given-names></name><name><surname>Whitehead</surname><given-names>AL</given-names></name><name><surname>Julious</surname><given-names>SA</given-names></name></person-group>. <article-title>An audit of sample size for pilot and
feasibility trials being undertaking in the United Kingdom registered in the
United Kingdom Clinical Research Network database</article-title>.
<source>BMC Med Res Methodol</source>.
<year>2013</year>;<volume>13</volume>:<fpage>104</fpage><pub-id pub-id-type="pmid">23961782</pub-id></mixed-citation>
              </ref>
              <ref id="bibr28-15347354211026757">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillon</surname><given-names>TW</given-names></name><name><surname>McDowell</surname><given-names>D</given-names></name><name><surname>Salimian</surname><given-names>F</given-names></name><name><surname>Conklin</surname><given-names>D.</given-names></name></person-group><article-title>Perceived ease of use and usefulness of bedside-computer
systems</article-title>. <source>Comput Nurs</source>.
<year>1998</year>;<volume>16</volume>:<fpage>151</fpage>-<lpage>156</lpage>.<pub-id pub-id-type="pmid">9611866</pub-id></mixed-citation>
              </ref>
              <ref id="bibr29-15347354211026757">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>FD.</given-names></name></person-group><article-title>Perceived usefulness, perceived ease of use, and user acceptance
of information technology</article-title>. <source>MIS Quarterly</source>.
<year>1989</year>:<volume>13</volume>:<fpage>319</fpage>-<lpage>340</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr30-15347354211026757">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JR</given-names></name></person-group>. <article-title>IBM computer usability satisfaction
questionnaires: psychometric evaluation and instructions for
use</article-title>. <source>Int J Hum Comput Interact</source>.
<year>1995</year>;<volume>7</volume>:<fpage>57</fpage>-<lpage>78</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr31-15347354211026757">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Fu</surname><given-names>MR</given-names></name></person-group>, <etal>et al</etal>. <article-title>Psychometric properties of
the breast cancer and lymphedema symptom experience index: the Chinese
version</article-title>. <source>Eur J Oncol Nurs</source>.
<year>2015</year>;<volume>20</volume>:<fpage>10</fpage>-<lpage>16</lpage>.<pub-id pub-id-type="pmid">26071198</pub-id></mixed-citation>
              </ref>
              <ref id="bibr32-15347354211026757">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>MR</given-names></name><name><surname>Cleland</surname><given-names>CM</given-names></name><name><surname>Guth</surname><given-names>AA</given-names></name></person-group>, <etal>et al</etal>. <article-title>L-Dex ratio in detecting
breast cancer-related lymphedema: reliability, sensitivity, and
specificity</article-title>. <source>Lymphology</source>.
<year>2013</year>;<volume>46</volume>:<fpage>85</fpage>-<lpage>96</lpage>.<pub-id pub-id-type="pmid">24354107</pub-id></mixed-citation>
              </ref>
              <ref id="bibr33-15347354211026757">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridner</surname><given-names>SH</given-names></name><name><surname>Dietrich</surname><given-names>MS</given-names></name><name><surname>Spotanski</surname><given-names>K</given-names></name></person-group>, <etal>et al</etal>. <article-title>A prospective study of L-Dex
values in breast cancer patients pretreamtent and through 12 months
postoperatively</article-title>. <source>Lymphat Res Biol</source>.
<year>2018</year>;<volume>16</volume>:<fpage>435</fpage>-<lpage>441</lpage>.<pub-id pub-id-type="pmid">30130147</pub-id></mixed-citation>
              </ref>
              <ref id="bibr34-15347354211026757">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedberg</surname><given-names>EC</given-names></name><name><surname>Ayers</surname><given-names>S.</given-names></name></person-group><article-title>The power of a paired t-test with a covariate</article-title>.
<source>Soc Sci Res</source>.
<year>2015</year>;<volume>50</volume>:<fpage>277</fpage>-<lpage>291</lpage>.<pub-id pub-id-type="pmid">25592936</pub-id></mixed-citation>
              </ref>
              <ref id="bibr35-15347354211026757">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasenoehrl</surname><given-names>T</given-names></name><name><surname>Keilani</surname><given-names>M</given-names></name><name><surname>Palma</surname><given-names>S</given-names></name><name><surname>Crevenna</surname><given-names>R.</given-names></name></person-group><article-title>Resistance exercise and breast cancer related lymphedema - a
systematic review update</article-title>. <source>Disabil Rehabil</source>.
<year>2020</year>;<volume>42</volume>:<fpage>26</fpage>-<lpage>35</lpage>.<pub-id pub-id-type="pmid">30638093</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
